78 related articles for article (PubMed ID: 19236756)
1. [Expressions of vascular endothelial growth factor and cyclooxygenase-2 in patients with multiple myeloma and its significance].
Bao HY; Zhu MQ; Jiang M; Dong NZ; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):99-101. PubMed ID: 19236756
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of serum vascular endothelial growth factor in patients with multiple myeloma].
Li X; Wei XZ; Liu JW; Geng CY; Chen WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):108-11. PubMed ID: 24598661
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma].
Shen JK; Dong LH; Qi H; Zhang GS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):68-71. PubMed ID: 15871192
[TBL] [Abstract][Full Text] [Related]
4. [Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma].
Usnarska-Zubkiewicz L; Mazur G; Wróbel T; Poreba M; Kuliczkowski K
Pol Arch Med Wewn; 2003 Jul; 110(1):719-24. PubMed ID: 14682206
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum vascular endothelial growth factor and interleukin-17 in patients with multiple myeloma].
Dong SS; Li GL; Yang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):344-7. PubMed ID: 22541095
[TBL] [Abstract][Full Text] [Related]
6. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between serum VEGF level and VEGF, COX-2 and MVD expression in breast cancer tissues].
Li EX; Wu YY; Shi F; Wu Y; Guo JJ; Dong DF
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):522-5. PubMed ID: 18069633
[TBL] [Abstract][Full Text] [Related]
8. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
9. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
10. [Study on the high expression of brain-derived neurotrophic factor in multiple myeloma patients and its possible mechanism].
Hu Y; Sun CY; Wang YD; Wei WN; Wu T; He WJ; Zhao S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):104-9. PubMed ID: 15748446
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of cytogenetic changes with VEGF and TRacp-5b levels among 60 elderly patients with multiple myeloma].
Cen L; Jiang Y; Zhang X; Chao H; Xiao R; Han W; Chen T; Lu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):602-5. PubMed ID: 27577203
[TBL] [Abstract][Full Text] [Related]
12. Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity.
Sato N; Hattori Y; Wenlin D; Yamada T; Kamata T; Kakimoto T; Okamoto S; Kawamura C; Kizaki M; Shimada N; Ote Y; Hata J; Ikeda Y
Jpn J Cancer Res; 2002 Apr; 93(4):459-66. PubMed ID: 11985797
[TBL] [Abstract][Full Text] [Related]
13. [Serum levels of sVCAM-1, IL-18 and VEGF in patients with aplastic anemia and their clinical significance].
Liu RY; Wu YZ; Fan HL; Xu XY; Luo YG; Hu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):117-20. PubMed ID: 19236760
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer].
Li EX; Shi F; Wu YY; Wu Y; Guo JJ; Dong DF
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):88-91. PubMed ID: 18353210
[TBL] [Abstract][Full Text] [Related]
15. [Expression of cyclooxygenase-2 and vascular endothelial growth factor in human prostate cancer and its significance].
Jin TX; Li XG; Wu WY; Piao DM; Feng JY; Sang J
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):207-10. PubMed ID: 16597032
[TBL] [Abstract][Full Text] [Related]
16. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
Zhao J; Hu J; Cai J
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
[TBL] [Abstract][Full Text] [Related]
17. Aqueous humor endothelin-1 (Et-1), vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) levels in Mexican glaucomatous patients.
Iwabe S; Lamas M; Vásquez Pélaez CG; Carrasco FG
Curr Eye Res; 2010 Apr; 35(4):287-94. PubMed ID: 20373895
[TBL] [Abstract][Full Text] [Related]
18. [Blood vessel multiply and significance of expression of Cox-2, VEGF in pterygium].
Yan M; Li Z; Liu G; Peng C; Zhou Y; Wang F
Yan Ke Xue Bao; 2007 Mar; 23(1):20-4. PubMed ID: 17444036
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
[TBL] [Abstract][Full Text] [Related]
20. Interrelationship and expression profiling of cyclooxygenase and angiogenic factors in Indian patients with multiple myeloma.
Khan R; Sharma M; Kumar L; Husain SA; Sharma A
Ann Hematol; 2013 Jan; 92(1):101-9. PubMed ID: 22971811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]